Benzinga's Top Upgrades

By: via Benzinga
Analysts at SunTrust Robinson Humphrey upgraded Amedisys Inc (NASDAQ: AMED) from Neutral to Buy. The price target for Amedisys has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.